UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force
View all comments(0)
May 5 (Reuters) - UNITY Biotechnology Inc UBX.O:
UNITY BIOTECHNOLOGY INC - COMPANY ESTIMATES $3.7 MILLION CASH EXPENSES FOR REDUCTION IN FORCE - SEC FILING
UNITY BIOTECHNOLOGY INC - REDUCTION IN FORCE EXPECTED TO BE COMPLETED BY MAY 15, 2025 - SEC FILING
UNITY BIOTECHNOLOGY INC - CEO ANIRVAN GHOSH, CFO LYNNE SULLIVAN, AND ALEXANDER NGUYEN TO TERMINATE EMPLOYMENT - SEC FILING
Source text: [ID:n0000950170-25-063167]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.